One of the Minnesota Vikings' longest-tenured players, fullback C.J. Ham's body has taken its toll from the 2024 season. The ...

Norchad Omier had 22 points and 12 rebounds, V.J. Edgecombe scored 21 points and Baylor defeated Utah 76-61 on Saturday. Leading 61-53 with five minutes left, Baylor outscored the Utes 9-2 over the ...

Johnson & Johnson (J&J) MedTech has reported a 4.8% growth in global sales in 2024, though it expects its 2025 outlook to remain affected by weak demand in China. J&J MedTech generated sales of $ ...

Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading on Wednesday, marking its biggest intraday drop since July 2023, even as the healthcare giant posted better-than-expected financials for Q4 ...

J&J said that about a third of adults will not respond to oral antidepressants alone. Sign up here to get The Results Are In with Dr. Sanjay Gupta every Friday from the CNN Health team.

Spravato was already available in the market before today's FDA approval and has already proven to be a financial success for J&J but only as an adjunct therapy to oral antidepressants for TRD.

Currently, marketing of the product in Japan is conducted by Janssen Pharma, a J&J subsidiary. All the news that moves the needle in pharma and biotech Exclusive features, podcasts, interviews, data ...